NEK3 and cancer: Additionally, understudied kinases CAMK1D, PNCK, and NEK3 have mutations with significant pan-cancer prognostic value, with PNCK being mutated frequently in LUAD and NEK3 in COAD and READ (p < 0.05; Table S5).